Evidence map›Paper›PMID 30192935›Full record

ArticleJournal of analytical toxicology2019

Reactive Oxygen Species Emissions from Supra- and Sub-Ohm Electronic Cigarettes.

Christina Haddad, Rola Salman, Ahmad El-Hellani, Soha Talih, Alan Shihadeh, Najat Aoun Saliba

Open access · bronzeAbstract read
In one paragraph

Article in Journal of analytical toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users-Results from Wave 1 PATH Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Christina HaddadChemistry Department, Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon.
Rola SalmanCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, Virginia, USA.
Ahmad El-HellaniChemistry Department, Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon.
Soha TalihCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, Virginia, USA.
Alan ShihadehCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, Virginia, USA.
Najat Aoun SalibaChemistry Department, Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon.
Virginia Commonwealth University · US

Funding

Training and Education Core p270-287P50DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI EISSENBERG, THOMAS EVAN · 2013 to 2017
$19.2M
NIDA NIH HHS P50 DA036105
6 · The paper itself

Abstract

Electronic cigarettes (ECIGs) are battery-powered devices that heat and vaporize solutions containing propylene glycol (PG) and/or vegetable glycerin (VG), nicotine and possible trace flavorants to produce an inhalable aerosol. The heating process can lead to the formation of reactive oxygen species (ROS), which are linked to various oxidative damage-initiated diseases. Several studies in the literature have addressed ROS emissions in ECIG aerosols, but the effects of power, ECIG device design and liquid composition on ROS are relatively unknown. In addition, ROS emissions have not been examined in the emerging high power, sub-Ohm device (SOD) category. In this study, an acellular 2',7'-dichlorofluorescin (DCFH) probe technique was optimized to measure ROS in ECIG aerosols. The technique was deployed to measure ROS emissions in SOD and supra-Ohm ECIGs while varying power, heater coil head design and liquid composition (PG/VG ratio and nicotine concentration). Liquids were made from analytical standards of PG, VG and nicotine and contained no flavorants. At high powers, ROS emissions in ECIGs and combustible cigarettes were similar. Across device designs, ROS emissions were uncorrelated with power (R2 = 0.261) but were highly correlated with power per unit area (R2 = 0.78). It was noticed that an increase in the VG percentage in the liquid yielded higher ROS flux, and nicotine did not affect ROS emissions. ROS emissions are a function of device design and liquid composition at a given power. For a given liquid composition, a promising metric for predicting ROS emissions across device designs and operating conditions is power per unit area of the heating coil. Importantly, ROS formation is significant even when the ECIG liquid consists of pure analytical solutions of PG and VG; it can therefore be viewed as intrinsic to ECIG operation and not solely a by-product of particular flavorants, contaminants or additives.

Indexed as

Electronic Nicotine Delivery SystemsVapingAerosolsConsumer Product SafetyDrug CompoundingEquipment DesignGlycerolHot TemperatureHumansInhalation ExposureMaterials TestingNicotineNicotinic AgonistsPropylene GlycolReactive Oxygen SpeciesRisk AssessmentAerosolsGlycerolNicotineNicotinic AgonistsPropylene GlycolReactive Oxygen Species

Identifiers

PMID30192935
PMCPMC6376456
OpenAlexW2889630213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.